Evidence map›Paper›PMID 32671048›Full record

ArticleFrontiers in bioengineering and biotechnology2020

Long-Term

Ingrid Garzón, Jesus Chato-Astrain, Carmen González-Gallardo, Ana Ionescu, Juan de la Cruz Cardona, Miguel Mateu, Carmen Carda, María Del Mar Pérez, Miguel Ángel Martín-Piedra, Miguel Alaminos

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. The origin of human epithelial tissue.Histology and histopathology · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ingrid GarzónTissue Engineering Group, Department of Histology, University of Granada, Granada, Spain.
Jesus Chato-AstrainTissue Engineering Group, Department of Histology, University of Granada, Granada, Spain.
Carmen González-GallardoDivision of Ophthalmology, University Hospital San Cecilio, Granada, Spain.
Ana IonescuBiomaterials Optics Group, Department of Optics, University of Granada, Granada, Spain.
Juan de la Cruz CardonaBiomaterials Optics Group, Department of Optics, University of Granada, Granada, Spain.
Miguel MateuTissue Engineering Group, Department of Histology, University of Granada, Granada, Spain.
Carmen CardaDepartment of Histology and Pathology, University of Valencia, Valencia, Spain.
María Del Mar PérezBiomaterials Optics Group, Department of Optics, University of Granada, Granada, Spain.
Miguel Ángel Martín-PiedraTissue Engineering Group, Department of Histology, University of Granada, Granada, Spain.
Miguel AlaminosTissue Engineering Group, Department of Histology, University of Granada, Granada, Spain.
Universidad de Granada · ESInstituto de Investigación Biosanitaria de Granada · ESUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHuman cornea substitutes generated by tissue engineering currently require limbal stem cells for the generation of orthotypical epithelial cell cultures. We recently reported that bioengineered corneas can be fabricated

methodsHere, we generated a partial thickness cornea model based on plastic compression nanostructured fibrin-agarose biomaterials with cornea epithelial cells on top, as an orthotypical model (HOC), or with HWJSC, as a heterotypical model (HHC), and determined their potential

resultsNo major side effects were seen 3 and 12 months after implantation of either bioengineered partial cornea model in rabbit corneas. Clinical results determined by slit lamp and optical coherence tomography were positive after 12 months. Histological and immunohistochemical findings demonstrated that

conclusionThese results suggest that both models are potentially useful to treat diseases requiring anterior cornea replacement, and that HHC may be an efficient alternative to the use of HOC which circumvents the need to generate cornea epithelial cell cultures.

Indexed as

artificial corneabioengineered corneaheterotypical human corneatissue engineeringWharton’s jelly stem cells

Identifiers

PMID32671048
PMCPMC7327129
OpenAlexW3036599898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.